Publication | Open Access
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
23
Citations
15
References
2022
Year
VaccinationVaccine DevelopmentMedicineHumoral ResponseImmunologySars-cov-2 VaccinationHumoral ImmunityImmunologic DiseaseMultiple SclerosisNeuroimmunologySix-month Humoral Response
| Year | Citations | |
|---|---|---|
Page 1
Page 1